(Q82672762)

English

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer

scientific article published on 27 January 2010

Statements

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit